General information | DisProt: | DP00539 | Name: | Methyl-CpG-binding protein 2 [Isoform A (Beta)] | Synonym(s): | MECP2_HUMAN
MeCp-2 protein
MeCp2
hMeCp2
| First appeared in release: | Release 3.7 (01/28/2008) | UniProt: | P51608 | UniGene: | Hs.200716 | SwissProt: | MECP2_HUMAN | TrEMBL: | | NCBI (GI): | 1708973 | Source organism: | Homo sapiens (Human) | Sequence length: | 486 | Percent disordered: | 91% | Homologues: | |
Native sequence |
10 20 30 40 50 60 | | | | | | MVAGMLGLRE EKSEDQDLQG LKDKPLKFKK VKKDKKEEKE GKHEPVQPSA HHSAEPAEAG - 60 KAETSEGSGS APAVPEASAS PKQRRSIIRD RGPMYDDPTL PEGWTRKLKQ RKSGRSAGKY - 120 DVYLINPQGK AFRSKVELIA YFEKVGDTSL DPNDFDFTVT GRGSPSRREQ KPPKKPKSPK - 180 APGTGRGRGR PKGSGTTRPK AATSEGVQVK RVLEKSPGKL LVKMPFQTSP GGKAEGGGAT - 240 TSTQVMVIKR PGRKRKAEAD PQAIPKKRGR KPGSVVAAAA AEAKKKAVKE SSIRSVQETV - 300 LPIKKRKTRE TVSIEVKEVV KPLLVSTLGE KSGKGLKTCK SPGRKSKESS PKGRSSSASS - 360 PPKKEHHHHH HHSESPKAPV PLLPPLPPPP PEPESSEDPT SPPEPQDLSS SVCKEEKMPR - 420 GGSLESDGCP KEPAKTQPAV ATAATAAEKY KHRGEGERKD IVSSSMPRPN REEPVDSRTP - 480 VTERVS
|
Functional narrative |
Methyl CpG-binding protein 2 (MeCP2) is a 53-kDa nuclear protein named for its methylated DNA-binding capacity. It can preferentially recognize methylated DNA and act as a methylation-dependent transcriptional repressor in vitro and in vivo. MeCP2 is also involved in the maintenance of condensed chromosomal superstructures and regulates mRNA splicing in vivo. It is able to interact with many different macromolecules and macromolecular complexes, including unmethylated and methylated DNA, nucleosomes and chromatin, transcriptional co-repressors, a histone H3 methyltransferase, Dnmt1 DNA methyltransferase, PU.1, Y box-binding protein 1 and other splicing factors. MeCP2 has two well defined functional domains. Residues 78-162 are required to specifically recognize methylated CpG dinucleotides and have been termed the methyl DNA binding domain (MBD). The minimal sequence needed to repress transfected DNA has been called the transcriptional repression domain (TRD) and consists of residues 207-310. The importance of MeCP2 function is underscored by its central role in the neurological disorder, Rett Syndrome, which is caused by a number of different nonsense, missense, and frameshift mutations scattered throughout the Mecp2 gene. Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A.
|
Map of ordered and disordered regions |
Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.
|
Region 1 | Type: | Disordered | Name: | High mobility group-like domain 2 (HMGD1) | Location: | 2 - 77 | Length: | 76 | Region sequence: |
VAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAGK AETSEGSGSAPAVPEA | Modification type: | Native
| PDB: | | Structural/functional type: | | Functional classes: | | Functional subclasses: | | Detection methods:
- Analytical ultracentrifugation (293 K; )
- Circular dichroism (CD) spectroscopy, far-UV (293 K; pH: 7.9; K2HPO4 10 mM; NaCl 20 mM)
| References:
- Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. "Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2." J Biol Chem. 2007; 282(20): 15057-64. PubMed: 17371874
| Comments:
|
Region 2 | Type: | Disordered | Name: | | Location: | 78 - 102 | Length: | 25 | Region sequence: |
SASPKQRRSIIRDRGPMYDDPTLPE | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | Function arises from the disordered state | Functional classes: | | Functional subclasses: | Protein-protein binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV (293 K; pH: 7.9; K2HPO4 10 mM; NaCl 20 mM)
| References:
- Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. "Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2." J Biol Chem. 2007; 282(20): 15057-64. PubMed: 17371874
| Comments:
|
Region 3 | Type: | Disordered | Name: | | Location: | 145 - 162 | Length: | 18 | Region sequence: |
VGDTSLDPNDFDFTVTGR | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | | Functional classes: | | Functional subclasses: | | Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV (293 K; pH: 7.9; K2HPO4 10 mM; NaCl 20 mM)
| References:
- Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. "Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2." J Biol Chem. 2007; 282(20): 15057-64. PubMed: 17371874
| Comments:
|
Region 4 | Type: | Disordered | Name: | High mobility group-like domain 2 (HMGD2) | Location: | 163 - 206 | Length: | 44 | Region sequence: |
GSPSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEG | Modification type: | Native
| PDB: | | Structural/functional type: | Function arises from the disordered state | Functional classes: | | Functional subclasses: | Nuclear localization
Protein-protein binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV (293 K; pH: 7.9; K2HPO4 10 mM; NaCl 20 mM)
- Analytical ultracentrifugation (293 K; )
| References:
- Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. "Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2." J Biol Chem. 2007; 282(20): 15057-64. PubMed: 17371874
| Comments:
|
Region 5 | Type: | Disordered | Name: | Transcriptional repression domain (TRD) | Location: | 207 - 310 | Length: | 104 | Region sequence: |
VQVKRVLEKSPGKLLVKMPFQTSPGGKAEGGGATTSTQVMVIKRPGRKRKAEADPQAIPK KRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRE | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | Function arises via a disorder to order transition | Functional classes: | Molecular recognition effectors
| Functional subclasses: | Intraprotein interaction
Protein-DNA binding
Protein-protein binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV (293 K; pH: 7.9; K2HPO4 10 mM; NaCl 20 mM)
- Electrophoretic Mobility Shift Assay (EMSA) (277 K; Binding buffer (RT, pH 7.4); DNA/NA (methylated or unmethylated) 200 ng; polypeptide construct, varying amts. (TRD, TRD-CTD{alpha} or TRD-CTD{alpha}-CTD{beta}); TAE (buffer, pH8.3); unmethylated DNA competitor or mononucleosome (added when DNA or NA used as substrate) 400 ng)
| References:
- Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. "Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2." J Biol Chem. 2007; 282(20): 15057-64. PubMed: 17371874
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
| Comments:Ghosh, et al. (2010), found a disorder-to-order structure/function relationship for the TRD.
|
Region 6 | Type: | Disordered | Name: | N-terminal domain (NTD) | Location: | 1 - 90 | Length: | 90 | Region sequence: |
MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAG KAETSEGSGSAPAVPEASASPKQRRSIIRD | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | Function arises from the disordered state | Functional classes: | Molecular recognition effectors
| Functional subclasses: | Intraprotein interaction
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV
- Electrophoretic Mobility Shift Assay (EMSA) (277 K; Binding buffer (RT, pH 7.4); DNA/NA (methylated or unmethylated) 200 ng; polypeptide construct, varying amts. (NTD, NTD-MBD or NTD-MBD-ID); TAE (buffer, pH 8.3); unmethylated DNA competitor or mononucleosome (added when DNA or NA used as substrate) 400 ng)
| References:
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
| Comments:Ghosh, et al. (2010), found that MBD activity is enhanced by its flanking domains of NTD and ID.
|
Region 7 | Type: | Ordered | Name: | Methylated-DNA Binding Domain (MBD) | Location: | 75 - 164 | Length: | 90 | Region sequence: |
PEASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRS KVELIAYFEKVGDTSLDPNDFDFTVTGRGS | Modification type: | Engineered
Fragment
| PDB: | 3C2I:A | Structural/functional type: | Function arises from the ordered state | Functional classes: | Molecular recognition effectors
| Functional subclasses: | Intraprotein interaction
Protein-DNA binding
Protein-protein binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV
- Electrophoretic Mobility Shift Assay (EMSA) (277 K; Binding buffer (RT, pH 7.4); DNA/NA (methylated or unmethylated) 200 ng; polypeptide construct, varying amts. (MBD, NTD-MBD, MBD-ID or NTD-MBD-ID); TAE (buffer, pH 8.3); unmethylated DNA competitor or mononucleosome (added when DNA or NA used as substrate) 400 ng)
| References:
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
| Comments:Ghosh, et al. (2010), found that MBD activity is enhanced by its flanking domains of NTD and ID.
|
Region 8 | Type: | Disordered | Name: | Intervening Domain (ID) | Location: | 165 - 210 | Length: | 46 | Region sequence: |
PSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEGVQVK | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | Function arises via a disorder to order transition | Functional classes: | Molecular recognition effectors
| Functional subclasses: | Intraprotein interaction
Protein-DNA binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV
- Electrophoretic Mobility Shift Assay (EMSA) (277 K; Binding buffer (RT, pH 7.4); DNA/NA (methylated or unmethylated) 200 ng; polypeptide construct, varying amts. (ID, MBD-ID or NTD-MBD-ID); TAE (buffer, pH 8.3); unmethylated DNA competitor or mononucleosome (added when DNA or NA used as substrate) 400 ng)
| References:
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
| Comments:Ghosh, et al. (2010), found that MBD activity is enhanced by its flanking domains of NTD and ID.
|
Region 9 | Type: | Disordered | Name: | C-terminal domain, alpha subunit (CTD-alpha) | Location: | 261 - 330 | Length: | 70 | Region sequence: |
PQAIPKKRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRETVSIEVKEVV KPLLVSTLGE | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | Relationship to function unknown | Functional classes: | Molecular recognition effectors
| Functional subclasses: | Intraprotein interaction
Protein-DNA binding
Protein-protein binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV
- Electrophoretic Mobility Shift Assay (EMSA) (277 K; Binding buffer (RT, pH 7.4); DNA/NA (methylated or unmethylated) 200 ng; polypeptide construct, varying amts. (CTD{alpha} or TRD-CTD{alpha}-CTD{beta}); TAE (buffer, pH 8.3); unmethylated DNA competitor or mononucleosome (added when DNA or NA used as substrate) 400 ng)
| References:
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
| Comments:
|
Region 10 | Type: | Disordered | Name: | C-terminal domain, beta subunit (CTD-beta) | Location: | 335 - 486 | Length: | 152 | Region sequence: |
GLKTCKSPGRKSKESSPKGRSSSASSPPKKEHHHHHHHSESPKAPVPLLPPLPPPPPEPE SSEDPTSPPEPQDLSSSVCKEEKMPRGGSLESDGCPKEPAKTQPAVATAATAAEKYKHRG EGERKDIVSSSMPRPNREEPVDSRTPVTERVS | Modification type: | Engineered
Fragment
| PDB: | | Structural/functional type: | | Functional classes: | Molecular recognition effectors
| Functional subclasses: | Intraprotein interaction
Protein-DNA binding
Protein-protein binding
| Detection methods:
- Circular dichroism (CD) spectroscopy, far-UV
- Electrophoretic Mobility Shift Assay (EMSA) (277 K; Binding buffer (RT, pH 7.4); DNA/NA (methylated or unmethylated) 200 ng; polypeptide construct, varying amts. (CTD{beta} or TRD-CTD{alpha}-CTD{beta}); TAE (buffer, pH 8.3); unmethylated DNA competitor or mononucleosome (added when DNA or NA used as substrate) 400 ng)
| References:
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
| Comments:Ghosh, et al. (2010), found that CTD-beta bound to nucleosomal arrays (NA) but not to pure DNA by itself.
|
References |
- Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. "Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2." J Biol Chem. 2007; 282(20): 15057-64. PubMed: 17371874
- Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. "Unique physical properties and interactions of the domains of methylated DNA binding protein 2." Biochemistry. 2010; 49(20): 4395-410. PubMed: 20405910
|
Comments |
Ghosh, et al. (2010), found that MeCP2 consists of six domains, and divides into two functional units. The NTD-MBD-ID unit functions in methylation-dependent and methylation-independent DNA binding, while the TRD-CTD{alpha}-CTD{beta} unit functions in chromatin compaction and oligomerization. The domains of each unit interact synergistically.
AV (7-7-2010) PubMed: 17371874
|
If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us. |
Disprot-footer
|